GRK2 Protein — G Protein-Coupled Receptor Kinase 2
📖 Wiki Page
protein817 wordssynced 2026-04-02
GRK2 Protein — G Protein-Coupled Receptor Kinase 2
Introduction
Grk2 Protein — G Protein Coupled Receptor Kinase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
GRK2 Protein — G Protein-Coupled Receptor Kinase 2
Introduction
Grk2 Protein — G Protein Coupled Receptor Kinase 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GRK2 (G protein-coupled Receptor Kinase 2), also known as ADRBK1 (Beta-adrenergic Receptor Kinase 1), is a member of the GRK family of serine/threonine kinases. GRK2 plays a critical role in regulating G protein-coupled receptor (GPCR) signaling through receptor phosphorylation and arrestin recruitment. Beyond GPCR regulation, GRK2 modulates numerous signaling pathways relevant to neurodegeneration, including dopaminergic signaling, inflammation, and cell survival.
Structure
GRK2 contains three distinct functional domains:
N-terminal RGS Domain (1-185 aa)
Regulator of G protein Signaling domain
Binds Gα subunits and accelerates GTP hydrolysis
Mediates protein-protein interactions
Contains the RH (RGS homology) fold
Kinase Domain (186-532 aa)
Catalytic serine/threonine kinase domain
Requires activation by Gβγ subunits
Phosphorylates serine/threonine residues on GPCR intracellular loops
Contains the conserved HRD motif in the catalytic loop
C-terminal PH Domain (533-675 aa)
Pleckstrin Homology domain
Binds phosphatidylinositol (PI) lipids at the plasma membrane
Facilitates membrane localization
Interacts with Gβγ subunits
Normal Function
GPCR Desensitization
GRK2 is best known for its role in GPCR regulation:
Receptor phosphorylation: Upon GPCR activation, GRK2 phosphorylates serine/threonine residues on the intracellular loops and C-terminal tail
Arrestin binding: Phosphorylated receptors bind β-arrestin, blocking further G protein coupling
Receptor internalization: Arrestin-receptor complexes are internalized via clathrin-coated pits
Signal switching: β-arrestin can initiate downstream signaling (biased agonism)
Substrate Receptors
GRK2 phosphorylates numerous GPCRs:
β-adrenergic receptors (β1AR, β2AR)
Dopamine receptors (D1R, D2R)
Muscarinic receptors (M2, M3)
Serotonin receptors (5-HT2R)
Glutamate receptors (mGluR5)
Non-GPCR Substrates
P53: Tumor suppressor phosphorylation
IκBα: [NF-κB](/entities/nf-kb) pathway regulation
ERK1/2: MAPK pathway modulation
Akt: PI3K/Akt signaling
Role in Neurodegenerative Diseases
Parkinson's Disease (PD)
GRK2 is critically involved in PD pathogenesis:
Dopaminergic dysfunction: Elevated GRK2 in the substantia nigra of PD patients
D2 receptor desensitization: Enhanced GRK2 activity leads to D2R hypofunction
α-synuclein interaction: GRK2 can phosphorylate α-synuclein at Ser129
Neuroinflammation: GRK2 regulates microglial activation via CXCR signaling
Alzheimer's Disease (AD)
APP processing: GRK2 may influence [amyloid precursor protein](/entities/app-protein) processing
Synaptic dysfunction: Alters AMPA and [NMDA receptor](/entities/nmda-receptor) trafficking
Cholinergic signaling: Modulates muscarinic [acetylcholine](/entities/acetylcholine) receptor function
The study of Grk2 Protein — G Protein Coupled Receptor Kinase 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, GRK2 in GPCR desensitization (1995) (1995)](https://pubmed.ncbi.nlm.nih.gov/11736479/)
[Unknown, GRK2 and Parkinson's disease (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29780642/)